Introduction
Transport of di-and tripeptides into cells is mediated by members of the SoLute Carrier 15 (SLC15) H + /oligopeptide cotransporter family (Daniel and Kottra, 2004) . To date, four peptide transporters have been cloned in mammals, namely PEPT1 (SLC15A1), PEPT2
(SLC15A2), PHT1 (SLC15A4) and PHT2 (SLC15A3). PEPT1 and PEPT2 have been characterized in great detail (Daniel and Kottra, 2004; Daniel et al., 2006; Rubio-Aliaga and Daniel, 2008) . Both proteins utilize an inwardly-directed H + gradient to translocate di-and tripeptides across plasma membranes. They also transport a variety of pharmacologically important compounds such as β-lactam antibiotics, renin inhibitors, the aminopeptidase inhibitor bestatin, -aminolevulinic acid and many selected pro-drugs (Brandsch et al., 2008; Rubio-Aliaga and Daniel, 2008) . PEPT1 is a low-affinity/high-capacity transporter, mainly expressed in small intestinal epithelial cells and, to a smaller extent, in renal proximal tubular cells and bile duct epithelium. PEPT2 is a high-affinity/low-capacity transporter and is widely expressed within the organism; in particular, in renal proximal tubular cells and, at lower levels, in central and peripheral nervous system, lung, lactating mammary gland, spleen, pancreas, pituitary gland, testis, prostate, ovary, uterus and eye. PHT1 and PHT2 have been cloned from a rat brain cDNA library (Yamashita et al., 1997; Sakata et al., 2001) and recently PHT1 has also been cloned from the human placental trophoblast BeWo cell line (Bhardwaj et al., 2006) . Information on transport properties, tissue distribution and subcellular localization of these transporters is very limited. Both proteins are capable of transporting the free amino acid L-histidine as well as selected di-and tripeptides in a H + -dependent manner (Yamashita et al., 1997; Sakata et al., 2001; Bhardwaj et al., 2006) . PHT1
is abundantly expressed in brain, eye, lung, gastrointestinal tract and placenta (Yamashita et al., 1997; Herrera-Ruiz et al., 2001; Bhardwaj et al., 2006) , while PHT2 is mainly expressed
Page 4 of 32 A c c e p t e d M a n u s c r i p t 4 in lymphatic system, lung, spleen and thymus, and weakly in brain, liver, adrenal gland and heart (Sakata et al., 2001 ). Both proteins contain in their cytoplasmic domains di-leucine motifs related to sorting to endosomes and lysosomes (Yamashita et al., 1997; Sakata et al., 2001; Bhardwaj et al., 2006) , and the rat PHT2 protein has been localized to the lysosomal membrane (Sakata et al., 2001) . However, to date it is not clear whether the peptide/histidine transporters are located on the plasma membrane or represent lysosomal proteins.
Although expression of the SLC15 transporters has been studied in several tissues, little is known about their presence in thyroid. To our knowledge, information on expression in the thyroid is limited to a real-time reverse transcription-polymerase chain reaction (RT-PCR) assay in human tissue (Nishimura and Naito, 2005) , while studies on functional transport of small peptides in epithelial thyroid cells are completely lacking. Nevertheless, it is of particular interest to study expression and function of peptide transporters in the thyroid as there a considerable turnover of proteins occurs. In fact, thyroid hormones production depends on cycles of synthesis and degradation of thyroglobulin (Tg) (Marinò and McCluskey, 2000; Brix et al., 2001 ) and SLC15 transporters in thyroid follicular cells could be involved in the transport of the small peptides derived from Tg synthesis/recycling processes.
We investigated whether and which peptide transporters are expressed in thyroid cells. More specifically, we characterized the transport function by using the fluorophore-conjugated dipeptide derivative β-Ala-Lys-N -7-amino-4-methyl-coumarin-3-acetic acid (Ala-Lys-AMCA) in both intact rat thyroid slices and rat thyroid PC Cl3 cells (Fusco et al., 1987) Medina and Santisteban, 2000; Kimura et al., 2001 ).
This study contains the first experimental evidence of functional expression of peptide transporters in follicular thyroid cells.
Materials and Methods

Materials
Calf serum, L-glutamine, penicillin/streptomycin and Coon's modified Ham's F12 culture medium (Coon's) were from Labtek Eurobio (Milan, Italy). Hydrocortisone, transferrin, Lglycyl-L-histidyl-L-lysine acetate and somatostatin were from ICN Biomedicals (Costa Mesa, CA). Sigma was the source for all the other chemicals.
Animals
Adult ( fluorescence microscope (Nikon Corporation, Tokyo, Japan) using filter block UV-2A (bandpass filter 330-380 nm for excitation; long-pass filter 420 nm for emission).
Cell culture
PC Cl3 cells were grown in Coon's, supplemented with calf serum (5%), L-glutamine (2 mM), penicillin (100 U/ml), streptomycin (100 ng/ml) and a mixture of hormones and growth factors consisting of insulin (1 µg/ml), hydrocortisone (3.62 µg/ml), TSH (1 mU/ml), somatostatin (10 ng/ml), transferrin (5 µg/ml), L-glycyl-L-histidyl-L-lysine (20 ng/ml) (Fusco et al., 1987) . The cells were maintained in a water-saturated atmosphere of 5% CO 2 and 95% air (37 °C). Cells were transferred to new plates every 3-5 days and the culture medium was changed every 2-3 days. Fresh medium was always added 24 h prior to an experiment. The cells were harvested with a 0.3% trypsin solution.
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Uptake and fluorescence microscopy in PC Cl3 cells
Transport studies with Ala-Lys-AMCA were performed as described (Dieck et al., 1999) .
Briefly, PC Cl3 cells were seeded on 24-well plates and used 1-2 days after plating (80-90% confluence). After growth medium removal, the cells were washed twice in 1 ml sodium medium (in mM: 137 NaCl, 5.4 KCl, 2.8 CaCl 2 , 1.2 MgSO 4 , 10 HEPES, pH 7.4 with Tris; 37 °C). Uptake was started by adding 0.5 ml sodium medium containing Ala-Lys-AMCA at the indicated concentrations, prolonged for the indicated times, and terminated by removing the uptake medium and washing the cells thrice with ice-cold stop solution (in mM: 132 NaCl, 14
Tris, 5 carnosine; pH 7.4 with HCl). For pH-dependence analysis, uptake experiments were performed as described above, but using sodium medium in which pH was adjusted at 5. slides, and embedded in mounting medium containing 1,4-diazabicyclo-(2,2,2)-octane (Sigma) for microscopic examination. Uptake of Ala-Lys-AMCA was assessed by fluorescence microscopy using a Nikon Eclipse E800 fluorescence microscope equipped with the appropriate filter combinations.
RT-PCR
Total RNA was isolated from PC Cl3 cells, rat thyroid and control tissues using TRIZOL Reagent (Invitrogen; Carlsbad, CA), and used (5 g) to perform RT with oligo(dT) 12-18 and SuperScript III First-Strand Synthesis System for RT-PCR (Invitrogen). The resulting cDNA (2 l) was used to perform PCR with Platinum Taq DNA polymerase (Invitrogen) and primers as from rat sequences (Table 1) . Primers for β-actin were used as an internal control. A c c e p t e d M a n u s c r i p t 9 system equipped with a CCD camera (Bio-Rad Laboratories, Hercules, CA). Their identity was confirmed by cloning and sequencing.
Semiquantitative (relative-quantitative) RT-PCR
Semiquantitative (relative-quantitative) RT-PCR analysis of SLC15 transcripts was performed using the Quantum RNA 18S internal standards system (Ambion Inc., Austin, TX). Briefly, total RNA was extracted from PC Cl3 cells grown in the presence or absence of TSH using TRIZOL Reagent. Five micrograms of total RNA were retro-transcribed using SuperScript III reverse transcriptase and random hexamers (Invitrogen) according to the manufacturer's protocol. Two microliters of the cDNA reaction mixture were used to perform duplex PCR with gene specific pairs of primers derived from rat sequences ( RT-PCR products were separated on a 2% agarose gel and stained with ethidium bromide.
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A c c e p t e d M a n u s c r i p t 10 Gel images were captured and band intensities were quantified using the Quantity One 4.1.1 software (Bio-Rad Laboratories). To normalize gene expression, the gene-to-18S ratio was calculated, based on the quantification of the captured bands intensities. Relative gene expression was reported as the percentage of the gene-to-18S ratio calculated in the absence of TSH, to which an arbitrary value of 100% was assigned. The identity of each amplified RT-PCR product was verified by cloning and sequencing.
Statistical analysis
Data points are given as means ± standard error. Within a single experiment, each point represents 3-4 replicate measurements. Each experiment was repeated at least 3 times.
Statistical analysis was carried out using Student's t-test or one-way analysis of variance (ANOVA), as appropriate. When indicated, post-hoc test (Bonferroni) was also performed.
All calculations were performed using Prism 4.0 (GraphPad; San Diego, CA).
Results
Uptake of Ala-Lys-AMCA into rat thyroid slices
Functional analysis of peptide transport in rat thyroid was performed on fresh tissue using Ala-Lys-AMCA as a reporter substrate. Incubation of thin rat thyroid slices with 25 μM AlaLys-AMCA revealed uptake of the molecule and intracellular accumulation of fluorescence in the epithelial cells of the thyroid follicles (Fig. 1A) . When uptake was performed in the presence of high concentrations (5 mM) of carnosine, the fluorescence signals were reduced
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A c c e p t e d M a n u s c r i p t 11 to a minimal extent (Fig. 1B) . Control incubations with neither Ala-Lys-AMCA nor carnosine revealed completely unstained samples (Fig. 1C) .
Functional characterization of dipeptide uptake in PC Cl3 cells
Ala-Lys-AMCA was used to analyze peptide transport in cultured PC Cl3 cells. The time course of Ala-Lys-AMCA uptake was linear for 120 min ( Fig. 2A ) and was greatly diminished by an excess of carnosine, which suggested competition for a common transport system. Therefore, incubation times for all successive experiments were kept at 90 min. AlaLys-AMCA transport as a function of Ala-Lys-AMCA concentration was a saturable process that followed Michaelis-Menten kinetics with a K m of 75.9 ± 5.3 μM and a J max of 5.0 ± 0.17 pmol/min x mg protein· (Fig. 2B) . After Eadie-Hofstee transformation, a linear relationship was observed (Fig. 2C) , indicating the occurrence of a single transport system. As expected, Ala-Lys-AMCA transport was pH-dependent, with uptake increasing at more acidic extracellular pH (Fig. 2D ).
Specific uptake of Ala-Lys-AMCA in PC Cl3 cells was also assessed by fluorescence microscopy. Figure 3 shows representative bright-field and fluorescence images of cells incubated in a medium containing 25 µM Ala-Lys-AMCA or 25 µM Ala-Lys-AMCA plus 5 mM carnosine, glycyl-sarcosine or L-histidine. PC Cl3 cells displayed a bright blue fluorescence when incubated for 90 min with Ala-Lys-AMCA (Fig. 3B) . Ala-Lys-AMCA uptake was inhibited by the concurrent application of either carnosine (Fig. 3C ) or glycylsarcosine ( Fig. 3D ), which reduced cell-associated fluorescence to background levels. On the other hand, accumulation of Ala-Lys-AMCA was not reduced by L-histidine (Fig. 3E ), a substrate of PHT1 and PHT2. Control experiments with neither Ala-Lys-AMCA nor competitors revealed completely unstained cells (Fig. 3F ).
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mRNA expression analysis of SLC15 transporters in rat thyroid and PC Cl3 cells
Expression of SLC15 transporters putatively involved in the transport of di-and tripeptides in rat thyroid gland and PC Cl3 cells was analyzed by RT-PCR using rat-derived primer pairs specific for each SLC15 family member (Table 1) . Representative data are summarized in Fig. 4 . RNA from rat intestine, kidney, brain and spleen was used as positive control to test sensitivity of PEPT1, PEPT2, PHT1 and PHT2 primer pairs, respectively. RT-PCR revealed the presence of mRNA transcripts for PEPT2 as well as for PHT1 in both rat thyroid gland and PC Cl3 cells ( Fig. 4B and Fig. 4C ). Furthermore, using rat PHT2-specific primers a faint amplification product was obtained from total RNA isolated from rat thyroid gland but not from PC Cl3 cells (Fig. 4D ). PEPT1 mRNA expression was not detectable in both thyroid and PC Cl3 cells (Fig. 4A ). All amplification products were sub-cloned and sequenced to confirm their identity (data not shown).
Effect of TSH on mRNA expression of SLC15 transporters in PC Cl3 cells
Semiquantitative (relative-quantitative) RT-PCR analysis was performed to examine the expression of PEPT1, PEPT2, PHT1 and PHT2 mRNA in PC Cl3 cells grown for 48 h either in the absence of TSH (0 mU/ml) or in the presence of two increasing TSH (0.1 and 1 mU/ml) concentrations. A significant up-regulation of the mRNA levels of PEPT2 (one-way ANOVA/Bonferroni post-hoc test) was observed passing from cells incubated in the absence of TSH (reference value = 100%) to cells incubated with TSH 0.1 mU/ml (113.5 ± 1.0%; P < 0.001; n = 3) and 1 mU/ml (128.8 ± 1.1%; P < 0.001; n = 3) (Fig. 5) . No significant changes in PHT1 mRNA expression (one-way ANOVA/Bonferroni post-hoc test) were observed in A c c e p t e d M a n u s c r i p t 13 both TSH 0.1 mU/ml (97.3 ± 1.7%; P > 0.05; n = 3) and 1 mU/ml (98.0 ± 2.3%; P > 0.05; n = 3) with respect to the absence of TSH (reference value = 100%) (Fig. 5) . On the other hand, PEPT1 and PHT2 mRNA signals were not detected in either the absence or the presence of TSH (Suppl. Fig. 1 ; see also Fig. 4 ).
Discussion
In this study we demonstrated the presence of specific mechanisms for peptide transport in thyroid follicular cells. Ala-Lys-AMCA was chosen as a reporter molecule to investigate peptide transport in rat thyroid tissue and cultured cells because it represents a good substrate for peptide transporters, with its high stability to enzymatic proteolysis, and allows direct visualization of peptide transport in both ex vivo and in vitro uptake experiments (Wenzel et al., 1998; Dieck et al., 1999; Groneberg et al., 2001; Groneberg et al., 2002a; Groneberg et al., 2002b; Groneberg et al., 2004; Rühl et al., 2005) . Ex vivo, Ala-Lys-AMCA transport activity was directly localized in virtually all epithelial follicular cells of the rat thyroid gland.
The specificity of Ala-Lys-AMCA uptake by these cell type was supported by the following evidences: 1) passive uptake of Ala-Lys-AMCA by diffusion was excluded by the lack of staining in non-follicular cells (e.g. C cells, accessory cells); 2) intracellular Ala-Lys-AMCA accumulation was competitively inhibited by high concentrations of carnosine, a typical substrate for SLC15 transporters. In agreement with the ex vivo experiments, peptide transport activity was demonstrated in PC Cl3 cells, an in vitro model of rat thyroid follicular cells that retains many properties of the normally differentiated thyrocyte (Fusco et al., 1987) .
Ala-Lys-AMCA accumulation by PC Cl3 cells was mediated by a saturable transport system resembling the PEPT2-type transporter. This conclusion is supported by the following facts:
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A c c e p t e d M a n u s c r i p t 14 that reported for Ala-Lys-AMCA in rat glial cells, that endogenously express the highaffinity PEPT2 transporter (Dieck et a., 1999) ; 2) Ala-Lys-AMCA uptake in PC Cl3 cells was inhibited by carnosine, a typical substrate of SLC15 transporters, and by Gly-Sar, a specific substrate of PEPT1 and PEPT2 but not of PHT1 (Bhardwaj et al., 2006) ; 3) Ala-Lys-AMCA accumulation in PC Cl3 cells was not inhibited by L-histidine, a substrate for PHT1 and PHT2 (Yamashita et al., 1997; Sakata et al., 2001 ).
RT-PCR experiments confirmed expression of PEPT2 in PC Cl3 cells and demonstrated its
physiological expression in rat thyroid gland. Interestingly, RT-PCR also revealed expression of mRNA for PHT1 in both thyroid gland and PC Cl3 cells. However, as described above, PHT1 did not seem to contribute to Ala-Lys-AMCA transport in PC Cl3 cells. This evidence would suggest intracellular localization of PHT1. In this respect, recent findings support the idea that PHT1, as well as PHT2, is localized in the lysosomal and/or early endosomal membranes (Sakata et al., 2001; Wada et al., 2005; Lee et al., 2009 ). However, because no data are available on the transport of Ala-Lys-AMCA by PHT1, we cannot exclude that PHT1 is expressed on the plasma membrane of PC Cl3 cells without participating to the uptake of the fluorescent substrate. In addition to PEPT2 and PHT1, RT-PCR has shown expression of PHT2 transcripts in rat thyroid gland but not in PC Cl3 cells. This finding is not surprising given that PHT2 mRNA is predominantly expressed in the lymphatic system (Sakata et al., 2001) and that the thyroid gland is endowed with a rich intra-glandular lymphatic network (Ohtani and Ohtani, 2008) .
TSH plays an important role in thyroid growth and differentiation, and several thyroid specific genes and differentiation markers (such as Tg, TPO, NIS and TSH receptor), thyroid Overall, these data provide the first experimental evidence for functional and molecular expression of PEPT2 in the epithelial cells of thyroid follicles. In the thyroid gland, epithelial cells (thyrocytes) are organized as follicles delimiting a closed compartment, the follicular lumen. Thyrocytes produce large quantities of Tg, the precursor of thyroid hormones, which is secreted into the lumen of the thyroid follicles and stored in a covalently cross-linked form.
Release of thyroid hormones requires internalization of Tg by thyroid epithelial cells and successive proteolytic degradation within lysosomes (Marinò and McCluskey, 2000) .
Recently, it has been demonstrated that limited proteolysis of Tg at the surface of thyroid epithelial cells precedes its endocytosis. This process is mediated by secreted cysteine proteases (e.g. cathepsins B, K and L) and leads to the solubilization of the covalently crosslinked Tg and to the rapid liberation of thyroxine from the pro-hormone (Brix et al., 1996; Tepel et al., 2000; Brix et al., 2001; Friedrichs et al., 2003) . According to this scenario, at the thyroid follicular level PEPT2 may be localized, as generally found in epithelia (Daniel and Kottra, 2004; Daniel et al., 2006; Rubio-Aliaga and Daniel, 2008) , at the apical membrane of the thyrocyte where it could be involved in the uptake and recycling of peptide-bound amino acids derived from the extracellular Tg proteolysis occurring in the lumen of the thyroid follicles.
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In the last few years, two PEPT2-deficient mice lines have been generated by independent groups (Rubio-Aliaga et al., 2003; Shen et al., 2003) . PEPT2 null-mice were healthy and displayed no obvious abnormalities in the kidney or brain. Our results point to the need to assess the effects of the PEPT2 deletion on thyroid functions and Tg metabolism.
Interestingly, in this study we provide indications that PHT1 transcripts are also expressed in thyroid follicular cells. Our results support the hypothesis (Sakata et al., 2001; Ocheltree et al., 2003; Wada et al., 2005; Bhardwaj et al., 2006; Lee et al., 2009 ) that PHT1 is located on the membrane of intracellular organelles, such as lysosomes and early endosomes. Although further studies are required to define the function of PHT1 in the thyroid epithelial cells, at least in theory this peptide/histidine transporter in the lysosomal membrane of thyrocytes could be important for the lysosome-to-cytosol release of short chain peptides as end products of Tg degradation.
In summary, this study represents the first description of the functional expression of PEPT2 in rat thyroid epithelial cells. PEPT2 could be relevant for removal/recycling of peptide fragments generated in the thyroid follicular lumen from the process of extracellular Tg proteolysis.
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